Nexalin Technology, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Nexalin Technology, Inc. (NXL) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $350.18 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-12
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $553.11K, a 1063.37% increase year-over-year.
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $47.54K.
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$33.98K, a 378.07% decline year-over-year.
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $12.22K.
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $80.30K.
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$5.75K, a 101.38% decline from fiscal 2023.
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $417.49K.
- Nexalin Technology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$499.04K, a 185.55% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $350.18K 10-Q · filed 2026-08-12 | ||||
| 2026-03-31 | $553.11K 10-Q · filed 2026-05-08 | ||||
| 2025-12-31 | $80.30K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $15.59K 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | -$143.16K 10-Q · filed 2026-08-12 | ||||
| 2025-03-31 | $47.54K 10-Q · filed 2026-05-08 | ||||
| 2024-12-31 | -$5.75K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$498.81K 10-Q · filed 2025-11-14 | ||||
| 2024-06-30 | $268.57K 10-Q · filed 2025-08-06 | ||||
| 2024-03-31 | -$33.98K 10-Q · filed 2025-05-13 | ||||
| 2023-12-31 | $417.49K 10-K/A · filed 2025-09-23 | $417.49K 10-K · filed 2024-03-27 | |||
| 2023-09-30 | $198.65K 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | $68.98K 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $12.22K 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | -$499.04K 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $7.20M 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | -$370.44K 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$203.17K 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | $583.34K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $57.99K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |